
南美洲和中美洲除颤器市场预测至 2028 年 - COVID-19 影响和区域分析(按产品(植入式心脏复律除颤器和体外除颤器)和最终用户(医院和诊所、院前护理、公共通道、家庭护理场所和替代护理设施)
No. of Pages: 114 | Report Code: TIPRE00027796 | Category: Life Sciences
No. of Pages: 114 | Report Code: TIPRE00027796 | Category: Life Sciences
心血管疾病 (CVD) 是主要疾病发病和死亡的原因。不健康的生活习惯,包括吸烟、不良饮食、肥胖、缺乏运动和过量饮酒,是心血管疾病的主要原因。心血管疾病病例激增导致对除颤器的需求量很大,因为它是医院对心血管疾病患者进行复苏和护理的重要工具。随着国家医疗保健支出和各地区家庭可支配收入的增加,除颤器的使用预计将进一步增加,以更好地管理心血管疾病。此外,作为医院的重要仪器,除颤器的需求如此之高,自动体外除颤器因其适用于心脏骤停 (SCA) 患者的复苏而受到特别关注。因此,心血管疾病发病率的不断上升推动了医院、家庭和其他医疗机构对各类除颤器的需求,预计这将进一步推动南美洲和中美洲的市场。
COVID-19 疫情严重影响了南美洲和中美洲的医疗服务和医疗旅游业。巴西、阿根廷、乌拉圭、智利、秘鲁和哥伦比亚受到另一波 COVID-19 大流行的影响。各种政府数据显示,自疫情爆发以来,巴西报告的伤亡人数为 622,251 人,病例数超过 2,350 万。此外,截至 2022 年 1 月 21 日的一周内,该国报告了 773,094 例病例,较前一周增加了 84%。同样,秘鲁报告的 COVID-19 病例增加了 113%,智利增加了 108%,乌拉圭每周报告的 COVID-19 病例增加了 37%。这一增长预示着另一波 SARS-CoV-2 的到来,预计将在 2022 年 1 月至 3 月达到高峰;预计该地区对除颤器的需求将增加。在巴西,只有少数患有心血管疾病的人使用除颤器。 Card Wherry 等人进行的一项题为“巴西有其他危险因素的初级预防患者植入式心脏除颤器 (ICD) 治疗的成本效益分析”的研究评估了植入式心脏除颤器的成本效益,并发现 ICD 疗法与未接受 ICD 治疗的患者相比,其终生折扣总成本(分别为 18,623 美元和 8,094 美元)和质量调整生命年(分别为 9.85 和 7.15)均较高。该研究展示了 ICD 对高危患者的实际应用和具有成本效益的模型。国际移民组织等组织的各种捐款和救援行动向该地区捐赠了除颤器。政府通过各种努力从多家制造商处采购了除颤器,以抗击 COVID-19 大流行。对医疗保健基础设施的影响和对该产品需求的增加预计将在未来几年弥补市场损失。
中南美洲除颤器市场收入及预测至 2028 年(百万美元)
< /p>
< /p>
Strategic insights for South and Central America Defibrillator involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 759.68 Million |
Market Size by 2028 | US$ 1,019.07 Million |
Global CAGR (2021 - 2028) | 4.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South and Central America Defibrillator refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Defibrillator Market is valued at US$ 759.68 Million in 2021, it is projected to reach US$ 1,019.07 Million by 2028.
As per our report South and Central America Defibrillator Market, the market size is valued at US$ 759.68 Million in 2021, projecting it to reach US$ 1,019.07 Million by 2028. This translates to a CAGR of approximately 4.3% during the forecast period.
The South and Central America Defibrillator Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Defibrillator Market report:
The South and Central America Defibrillator Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Defibrillator Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Defibrillator Market value chain can benefit from the information contained in a comprehensive market report.